Literature DB >> 12040434

Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia.

F Cobo1, A Martínez, M Pinyol, L Hernández, M Gómez, S Beá, J Esteve, M Rozman, F Bosch, A López-Guillermo, E Montserrat, E Campo.   

Abstract

To investigate the role of the cell cycle regulators p21(Waf1), p27(Kip1), retinoblastoma (Rb), and cyclin D1 in Richter's transformation of chronic lymphocytic leukemia (CLL), we analyzed 19 CLL and eight Richter's syndrome (RS) tumors, previously characterized for p53 and ARF/INK4a abnormalities. p21(Waf1)immunohistochemical expression was negative in 12 of 15 CLL (80%), whereas it was moderate or strong in three of seven RS (43%). p21(Waf1) gene was in germline configuration in all the tumors analyzed. Four immunohistochemical patterns of p53 and p21(Waf1) expression were observed: (1) p53-/p21- in 10 of 15 CLL (67%), but only in two of six RS (33%); (2) p53+/p21+ in three CLL (20%) and two RS (33%); (3) p53-/p21+ in one RS; and (4) p53++/p21- in two CLL and one RS. Two p53+/p21+ CLL evolved into RS. p53 mutations clustered around the p53++/p21- (two CLL and one RS) and p53-/p21- (one CLL and one RS) tumors. While the majority of CLL displayed strong p27 immunoreactivity, RS tumors were constantly p27-negative. p27(Kip1) gene was in germline configuration in all the tumors analyzed. Most CLL cases were negative for Rb expression. In contrast, all RS exhibited strong Rb expression. Cyclin D1 overexpression was only detected in one CLL evolving into RS and one RS. In conclusion, a p53+/p21- immunohistochemical pattern is shown exclusively by p53-mutated CLL/RS. Additionally, our results suggest a possible implication of moderate/strong p21(Waf1) expression, loss of p27 expression, and cyclin D1 overexpression in the Richter's transformation of CLL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12040434     DOI: 10.1038/sj.leu.2402529

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior.

Authors:  Eva Giné; Antoni Martinez; Neus Villamor; Armando López-Guillermo; Mireia Camos; Daniel Martinez; Jordi Esteve; Xavier Calvo; Ana Muntañola; Pau Abrisqueta; Maria Rozman; Ciril Rozman; Francesc Bosch; Elias Campo; Emili Montserrat
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

Review 2.  Richter's transformation in chronic lymphocytic leukemia.

Authors:  Apostolia-Maria Tsimberidou; Michael J Keating; William G Wierda
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

Review 3.  Recent advances in the diagnosis and therapy of Richter's syndrome.

Authors:  Ronan Swords; John Bruzzi; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

4.  Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome.

Authors:  Issa F Khouri; Roland Bassett; Nancy Poindexter; Susan O'Brien; Carlos E Bueso-Ramos; Yvonne Hsu; Alessandra Ferrajoli; Michael J Keating; Richard Champlin; Marcelo Fernandez-Vina
Journal:  Cancer       Date:  2011-03-31       Impact factor: 6.860

5.  Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation.

Authors:  Deepa Sampath; George A Calin; Vinay K Puduvalli; Gopal Gopisetty; Cristian Taccioli; Chang-Gong Liu; Brett Ewald; Chaomei Liu; Michael J Keating; William Plunkett
Journal:  Blood       Date:  2008-12-18       Impact factor: 22.113

6.  Richter transformation with c-MYC overexpression: report of three cases.

Authors:  Ling Wang; Azadeh Aghel; Brandon Peterson; Jessica Wang-Rodriguez; Huan-You Wang; Xianfeng Frank Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 7.  Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.

Authors:  Khadega A Abuelgasim; Hinna Rehan; Maha Alsubaie; Nasser Al Atwi; Mohammed Al Balwi; Saeed Alshieban; Areej Almughairi
Journal:  J Med Case Rep       Date:  2018-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.